| Dennis Damian Winters, MD | |
|
4403 Harrison Blvd, Suite 1815, Ogden, UT 84403-3271 | |
| (801) 387-6520 | |
| (801) 387-6525 |
| Full Name | Dennis Damian Winters |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 31 Years |
| Location | 4403 Harrison Blvd, Ogden, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194769604 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 6451965-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health | Murray, UT | Home health agency |
| Applegate Homecare | Ogden, UT | Home health agency |
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Ogden Regional Medical Center | Ogden, UT | Hospital |
| Logan Regional Hospital | Logan, UT | Hospital |
| Layton Hospital | Layton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ogden Clinic Specialty Services Llc | 1658781422 | 106 |
News Archive
Researchers at the Center for Smart and Connected Society at the University of Massachusetts Amherst recently released a new digital contact-tracing technique that is based on widely-deployed Wi-Fi technology.
Researchers at Lund University in Sweden have developed a completely new stimulation method, using ultra-thin microelectrodes, to combat severe pain.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has announced further positive data on the first forty subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma, with an objective response ("OR") observed in 61% of subjects and a mean Progression Free Survival ("PFS") of at least 11.1 months among those subjects achieving an OR.
Tabba Heart Institute and the Institute for Health Metrics and Evaluation at the University of Washington's School of Medicine are partnering to improve public knowledge and inform policymakers of cardiovascular health in Pakistan by collecting and sharing data, leveraging their expertise in health metrics sciences to provide more accurate estimates of the national and provincial burden of cardiovascular diseases in Pakistan.
› Verified 2 days ago
| Entity Name | Ogden Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578550083 PECOS PAC ID: 9638078033 Enrollment ID: O20040105000780 |
News Archive
Researchers at the Center for Smart and Connected Society at the University of Massachusetts Amherst recently released a new digital contact-tracing technique that is based on widely-deployed Wi-Fi technology.
Researchers at Lund University in Sweden have developed a completely new stimulation method, using ultra-thin microelectrodes, to combat severe pain.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has announced further positive data on the first forty subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma, with an objective response ("OR") observed in 61% of subjects and a mean Progression Free Survival ("PFS") of at least 11.1 months among those subjects achieving an OR.
Tabba Heart Institute and the Institute for Health Metrics and Evaluation at the University of Washington's School of Medicine are partnering to improve public knowledge and inform policymakers of cardiovascular health in Pakistan by collecting and sharing data, leveraging their expertise in health metrics sciences to provide more accurate estimates of the national and provincial burden of cardiovascular diseases in Pakistan.
› Verified 2 days ago
| Entity Name | Ogden Clinic Specialty Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114203668 PECOS PAC ID: 1658781422 Enrollment ID: O20201105001806 |
News Archive
Researchers at the Center for Smart and Connected Society at the University of Massachusetts Amherst recently released a new digital contact-tracing technique that is based on widely-deployed Wi-Fi technology.
Researchers at Lund University in Sweden have developed a completely new stimulation method, using ultra-thin microelectrodes, to combat severe pain.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has announced further positive data on the first forty subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma, with an objective response ("OR") observed in 61% of subjects and a mean Progression Free Survival ("PFS") of at least 11.1 months among those subjects achieving an OR.
Tabba Heart Institute and the Institute for Health Metrics and Evaluation at the University of Washington's School of Medicine are partnering to improve public knowledge and inform policymakers of cardiovascular health in Pakistan by collecting and sharing data, leveraging their expertise in health metrics sciences to provide more accurate estimates of the national and provincial burden of cardiovascular diseases in Pakistan.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Damian Winters, MD Po Box 5546, Denver, CO 80217-5546 Ph: (801) 475-3500 | Dennis Damian Winters, MD 4403 Harrison Blvd, Suite 1815, Ogden, UT 84403-3271 Ph: (801) 387-6520 |
News Archive
Researchers at the Center for Smart and Connected Society at the University of Massachusetts Amherst recently released a new digital contact-tracing technique that is based on widely-deployed Wi-Fi technology.
Researchers at Lund University in Sweden have developed a completely new stimulation method, using ultra-thin microelectrodes, to combat severe pain.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has announced further positive data on the first forty subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma, with an objective response ("OR") observed in 61% of subjects and a mean Progression Free Survival ("PFS") of at least 11.1 months among those subjects achieving an OR.
Tabba Heart Institute and the Institute for Health Metrics and Evaluation at the University of Washington's School of Medicine are partnering to improve public knowledge and inform policymakers of cardiovascular health in Pakistan by collecting and sharing data, leveraging their expertise in health metrics sciences to provide more accurate estimates of the national and provincial burden of cardiovascular diseases in Pakistan.
› Verified 2 days ago
Kurt D Bangerter, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd, Ste 1815, Ogden, UT 84403 Phone: 801-732-5900 Fax: 801-732-5988 | |
Jeffrey Clay Aucoin, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd Ste 1815, Ogden, UT 84403 Phone: 801-732-5900 Fax: 801-732-5988 | |
Blake G. Welling, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd, #1815, Ogden, UT 84403 Phone: 801-732-5900 Fax: 801-217-2327 |